Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Theravance Company Profile (NASDAQ:THRX)

Consensus Ratings for Theravance (NASDAQ:THRX) (?)
Ratings Breakdown: 2 Sell Rating(s), 4 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 1.86)
Consensus Price Target: $17.25 38.04% downside)

Current Analysts' Coverage Summary for Theravance (NASDAQ:THRX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/21/2014Stifel NicolausDowngradeUnderweight$12.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
7/18/2014ZacksReiterated RatingNeutral -> Neutral$28.00ViewTweet This Rating  Share This Rating on StockTwits
6/12/2014Citigroup Inc.DowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
6/6/2014Bank of AmericaInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
6/2/2014Robert W. BairdDowngradeOutperform -> Neutral$31.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
7/22/2013Morgan StanleyInitiated CoverageUnderweight$13.00ViewTweet This Rating  Share This Rating on StockTwits
7/19/2013Sanford C. BernsteinBoost Price TargetMarket Perform$30.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
4/19/2013S&P Equity ResearchBoost Price TargetBuy$32.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
4/18/2013Leerink SwannBoost Price TargetOutperform$34.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
1/29/2013Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
1/28/2013Piper JaffrayLower Price TargetOverweight$32.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/22/2012 forward)